BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36655348)

  • 1. "The Atherogenic Index of Plasma: A Powerful and Reliable Predictor for Coronary Artery Disease in Patients With Type 2 Diabetes".
    Ahmad M; Ahmad W; Kumar S
    Angiology; 2023 Sep; 74(8):801. PubMed ID: 36655348
    [No Abstract]   [Full Text] [Related]  

  • 2. The Atherogenic Index of Plasma: A Powerful and Reliable Predictor for Coronary Artery Disease in Patients With Type 2 Diabetes.
    Zhou K; Qin Z; Tian J; Cui K; Yan Y; Lyu S
    Angiology; 2021 Nov; 72(10):934-941. PubMed ID: 33949211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex difference in the relationship of the Atherogenic index of plasma with coronary artery lesions in diabetes: a cross-sectional study.
    Hu Y; Wang X; Luo C; Zheng T; Tian G
    Lipids Health Dis; 2023 Jan; 22(1):10. PubMed ID: 36681828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
    Ahmed S; Sobh R
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study.
    Ledru F; Ducimetière P; Battaglia S; Courbon D; Beverelli F; Guize L; Guermonprez JL; Diébold B
    J Am Coll Cardiol; 2001 May; 37(6):1543-50. PubMed ID: 11345363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis.
    Reinhard H; Wiinberg N; Hansen PR; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
    Cardiovasc Diabetol; 2011 Aug; 10():71. PubMed ID: 21812947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetes mellitus type 2: coronary calcifications as a predictor of coronary artery disease].
    Becker A; Knez A; Leber A; Boekstegers P; Steinbeck G
    Herz; 2004 Aug; 29(5):488-95. PubMed ID: 15340734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry.
    Nakamura H; Kataoka Y; Nicholls SJ; Puri R; Kitahara S; Murai K; Sawada K; Matama H; Iwai T; Honda S; Fujino M; Takagi K; Yoneda S; Otsuka F; Nishihira K; Asaumi Y; Tsujita K; Noguchi T
    Atherosclerosis; 2022 May; 349():183-189. PubMed ID: 35450750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective two-center study on the associations between microalbuminuria, coronary atherosclerosis and long-term clinical outcome in asymptomatic patients with type 2 diabetes mellitus: evaluation by coronary CT angiography.
    Kim JJ; Hwang BH; Choi IJ; Choo EH; Lim S; Koh YS; Lee JM; Kim PJ; Seung KB; Lee SH; Cho JH; Jung JI; Chang K
    Int J Cardiovasc Imaging; 2015 Jan; 31(1):193-203. PubMed ID: 25281423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.
    Qin Z; Zhou K; Li Y; Cheng W; Wang Z; Wang J; Gao F; Yang L; Xu Y; Wu Y; He H; Zhou Y
    Cardiovasc Diabetol; 2020 Feb; 19(1):23. PubMed ID: 32085772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the patient with diabetes and coronary artery disease: a contemporary review.
    Raymond T; Raymond R; Lincoff AM
    Future Cardiol; 2013 May; 9(3):387-403. PubMed ID: 23668743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between severity of coronary artery athesclerosis and duration and severity of diabetes mellitus in type 2 diabetic patients.
    Uddin SN; Siddiqui NI; Begum F; Malik F; Rahman S
    Mymensingh Med J; 2003 Jul; 12(2):85-8. PubMed ID: 12894038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Epicardial Fat Volume With the Extent of Coronary Atherosclerosis and Cardiovascular Adverse Events in Asymptomatic Patients With Diabetes.
    Venuraju SM; Lahiri A; Jeevarethinam A; Rakhit RD; Shah PK; Nilsson J
    Angiology; 2021 May; 72(5):442-450. PubMed ID: 33467865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence, Characteristics, and Volumes of Coronary Plaque Determined by Computed Tomography Angiography in Young Type 2 Diabetes Mellitus.
    Nezarat N; Budoff MJ; Luo Y; Darabian S; Nakanishi R; Li D; Sheidaee N; Kim M; Alani A; Matsumoto S; Rahmani S; Kanisawa M; Ceponiene I; Osawa K; Qi H; Hamal S; Kitslaar P; Broersen A; Flores F; Ipp E; Khazai B
    Am J Cardiol; 2017 May; 119(10):1566-1571. PubMed ID: 28343599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correspondence to: "Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors".
    Dobiasova M
    Atherosclerosis; 2021 Oct; 335():148. PubMed ID: 34563338
    [No Abstract]   [Full Text] [Related]  

  • 16. Is assessment of peripheral endothelial dysfunction useful tool for risk stratification of type 2 diabetic patients with manifested coronary artery disease?
    Bosevski M; Borozanov V; Tosev S; Georgievska-Ismail Lj
    Int J Cardiol; 2009 Jan; 131(2):290-2. PubMed ID: 17964674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.
    Qamar A; Khetarpal SA; Khera AV; Qasim A; Rader DJ; Reilly MP
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1880-8. PubMed ID: 26069232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherogenic Index of Plasma is Associated with Body Fat Level in Type 2 Diabetes Mellitus Patients.
    Song P; Xu L; Xu J; Zhang HQ; Yu CX; Guan QB; Zhao M; Zhang X
    Curr Vasc Pharmacol; 2018; 16(6):589-595. PubMed ID: 29299987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating sortilin level as a potential biomarker for coronary atherosclerosis and diabetes mellitus.
    Oh TJ; Ahn CH; Kim BR; Kim KM; Moon JH; Lim S; Park KS; Lim C; Jang H; Choi SH
    Cardiovasc Diabetol; 2017 Jul; 16(1):92. PubMed ID: 28728579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between serum galectin-3 levels and coronary atherosclerosis and plaque burden/structure in patients with type 2 diabetes mellitus.
    Ozturk D; Celik O; Satilmis S; Aslan S; Erturk M; Cakmak HA; Kalkan AK; Ozyilmaz S; Diker V; Gul M
    Coron Artery Dis; 2015 Aug; 26(5):396-401. PubMed ID: 25887000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.